Abstract
Introduction:
Biofilms are communities of microorganisms encased in a self-produced matrix, a structure that makes resident bacteria up to 1,000 times more resistant to antibiotics than their free-living, or planktonic, counterparts. Intriguingly, new methods that use reagents to release the biofilm-resident bacteria result in a transitory yet highly antibiotic sensitive phenotype. These newly released (NRel) bacteria are at least, if not more, sensitive to antibiotics than those in their planktonic form. Here, we sought to determine if the production of the NRel phenotype is reagent- dependent or can be accomplished by alternative means.
Methods:
Across four pathogenic bacteria: non-typeable Haemophilus influenzae (NTHI), methicillin resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and Streptococcus pneumoniae, we investigated whether rapid mechanical disruption of biofilms, or the use of a novel cationic depletion method in NTHI, could similarly induce this NRel phenotype. The presence of NRel was assessed by comparing the antibiotic sensitivity of the released bacteria to that of their planktonic counterparts. For NTHI specifically, we further characterized the phenotype by measuring the kinetics of antibiotic sensitivity via comparative plate counts over time. We also analyzed the relative expression levels of known NRel-associated genes using quantitative reverse transcription polymerase chain reaction (qRT-PCR).
Results:
We show that using either intense mechanical disruption or a cationic depletion method not only facilitate rapid biofilm disruption but produce the NRel phenotype. In each case, both NRel signature gene expression and the transient antibiotic sensitivity phenotypes were observed compared to planktonic cells.
Discussion:
Similar to methods using reagents, we found that mechanical or cationic depletion disruption of pathogenic bacterial biofilms were sufficient to trigger the NRel phenotype. These results are consistent with the NRel state potentially being a rate-dependent physiological response rather than being induced by specific chemical or biological agents. We discuss the changes in gene expression permissive to NRel and the possibility that rapid and premature release of bacteria from a biofilm fails to allow the resident bacteria to be sufficiently prepared for their biofilm free state. This new insight both expands our understanding of the NRel phenotype and provides further validation for our rapid-release therapeutic strategy.
1 Introduction
Bacterial biofilms significantly contribute to infection pathogenesis and chronicity (). These bacteria reside within a self-produced extracellular polymeric substance (EPS) matrix, which consists of many components, including extracellular DNA (eDNA), proteins, lipids, polysaccharides, and other biopolymers. According to the NIH, up to 80% of human bacterial infections go through a biofilm phase (), and they play a key role in such common chronic diseases as otitis media, chronic obstructive pulmonary disease, periodontitis, and cystic fibrosis, among others (; ; ). The global economic burden of biofilm-related healthcare costs was estimated to be almost $400 billion in 2019 (), thus underscoring the need for effective treatment options. However, the biofilm matrix provides a protective barrier against harsh environments, antimicrobials, and host immune effectors (; ; ), often leading to disease recurrence (). While biofilm stability is influenced by species-specific matrix components, a key factor contributing to the structural integrity of mature biofilms is the conversion of DNase sensitive eDNA in the B-form to the DNase-resistant Z-form, which accumulates due to the activity of DNABII proteins (). Bacteria in a biofilm state can be 1,000 times more resistant to conventional antibiotic treatments compared to their free living planktonically grown counterparts (; ; ). Importantly, new methods are needed to effectively treat these common and highly resistant biofilm-related infections.
A growing number of laboratories are working toward those treatment goals (; ; ; ). The approaches these laboratories are taking vary from triggering biofilm dispersal to actively disrupting the biofilm through various means. Dispersal is a bacteria-specific, programmed response to an induced signal, whereby resident bacteria actively escape the biofilm to colonize other sites and start the biofilm life cycle anew (). Disruption, however, is generally a fast, unprogrammed response to external factors, such as mechanical stress and shearing or reagents that actively target biofilm components to break them apart (). Current methods that use reagents to disrupt biofilms and rapidly release the resident bacteria yield a transient but highly antibiotic-sensitive phenotype wherein the released cells are often more antibiotic sensitive than their planktonic counterparts that seeded the original biofilm (; ; ; ; ; ; ).
In previous studies from our group (, ; ; ; ), we have utilized an epitope-targeted monoclonal antibody approach against the DNABII family of DNA binding proteins that serve as linchpins by binding to and converting B-DNA into Z-DNA which act as a structural support for the biofilm matrix. These monoclonal antibodies are directed against the DNA binding tip region of DNABII proteins and take advantage of the natural equilibrium of the DNA bound and unbound state of DNABII proteins. These antibodies in effect sequester the DNABII proteins in the unbound state and prevent their rebinding to the eDNA matrix and thereby shift the equilibrium of the proteins away from the eDNA matrix (; ). The induced equilibrium shift of the DNABII proteins out of the matrix results in a rapid collapse (within minutes) of the biofilm and release of the resident bacteria. These newly released (NRel) bacteria display a transient yet significantly increased antibiotic susceptibility (, ; ; ), and a unique gene expression profile ().
Many of these disruption methods are rapid in nature, occurring in the span of minutes (; ; ; ; ; ; ; ; ; ). According to our hypothesis, the rate of disruption is essential to produce the NRel phenotype so as to yield released bacteria that are ill-prepared via apropos gene expression to sufficiently protect themselves against the newly encountered harsh environment in the absence of the biofilm. Therefore, it stands to reason that the kinetics of the disruption would matter. To that end, and as a proof of concept, we sought to determine if NRel can be produced by other methods of similar kinetics, specifically rapid physical or mechanical means. This is important in that it would allow us to determine if the production of the NRel phenotype is not so much reagent dependent, but rather a result of the rapid nature of the disruption.
As we have demonstrated previously (, ; ; ), the NRel phenotype generally consists of three main pillars: increased antibiotic sensitivity, a transient kinetic profile, and a unique gene expression profile. Here, we evaluated four predominant respiratory pathogens [non-typeable Haemophilus influenzae (NTHI), methicillin resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and Streptococcus pneumoniae] using several reagent free and rapid disruption methods to determine if we could induce the NRel state and its three main hallmarks.
2 Materials and methods
2.1 Bacterial strains and growth
NTHI strain 86-028NP () was maintained frozen in LN2 at passage #4 on artificial medium since its original isolation from the nasopharynx of a deidentified child who underwent routine tympanostomy tube insertion due to chronic otitis media (). NTHI 86-028NP was grown in Brain Heart Infusion broth supplemented (sBHI) with hemin (2 μg/mL) (Sigma-Aldrich, St. Louis, MO; Cat no. H9039) and β-NAD (2 μg/mL) (Sigma-Aldrich, St. Louis, MOl Cat no. N1511) or Chocolate agar. MRSA [a clinical isolate from a child with cystic fibrosis ()] and P. aeruginosa strain 142-1 [an isolate from an ICU patient with nosocomial pneumonia, kindly provided by William Weiss, University of North Texas Health Sciences Center ()] were grown on Tryptic Soy agar (TSA) or in Tryptic Soy broth. S. pneumoniae 1121 [derived from an isolate of a child with otitis media, kindly provided by Jeffrey Weiser, New York University ()], was grown in Todd Hewitt Broth supplemented with 0.2% yeast extract or on Blood agar (TSA with 5% sheep’s blood). All organisms were grown at 37 °C in a humidified atmosphere with 5% CO2 for approximately 16 hours.
2.2 Antibiotics and determination of antibiotic concentration
Three antibiotics for each of the four respiratory tract pathogens listed above were selected for use in this study based on their clinical relevance, with a preference toward those that would be prescribed for a current infection of the respective bacteria, as well as to bridge from our previous work (, ) whereby we used the same antibiotics tested with our DNABII monoclonal antibody disruption approach. Minimum inhibitory concentrations (MIC) for each antibiotic as shown previously () were used as a starting point to determine the antibiotic concentration where the percent killing of planktonically grown cultures of each tested bacterium was between ∼15% and 25% so as to be able to demonstrate any enhanced sensitivity to killing by NRel bacteria. The organisms, antibiotics used, and their respective working concentrations are shown in Table 1.
TABLE 1
| Organism tested | Antibiotics used | Working concentrations (μg/mL) |
|---|---|---|
| NTHI 86-028NP | Trimethoprim + sulfamethoxazole* | 0.125 |
| Amoxicillin + clavulanate | 0.5 | |
| Clarithromycin | 1.0 | |
| MRSA | Vancomycin | 0.05 |
| Levofloxacin | 0.005 | |
| Linezolid | 0.1 | |
| P. aeruginosa 142-1 | Ceftazidime | 4.0 |
| Tobramycin | 2.0 | |
| Piperacillin | 2.0 | |
| S. pneumoniae 1121 | Vancomycin | 0.05 |
| Amoxicillin + clavulanate | 0.003 | |
| Trimethoprim + sulfamethoxazole* | 4.0 |
Organisms and antibiotics used in this study.
*Trimethoprim-sulfamethoxazole was prepared in a 1:19 ratio according to EUCAST guidelines as described previously (). The concentration value for trimethoprim-sulfamethoxazole is expressed as the concentration (μg/mL) of trimethoprim.
2.3 Mechanical disruption
NTHI was grown as described above in sBHI for 16 h at 37 °C with 5% CO2. The CFUs (colony forming units) released from these NTHI biofilms using a combination of sonication for 0–5 min, vortexing (Fisher analog vortex, Cat # 02215414, Model 9454FIALUS) at speed setting 10 with and without 6 mm borosilicate glass beads coated with SigmaCote™ (Sigma-Aldrich, St. Louis, MO) for up to 5 min and pipetting (Thermo Scientific™, Waltham, MA Finnpipette™ F2 20–200 μL model, Fisherbrand Redi-Tip™ Cat 02707501) multiple times for up to 5 min followed by serial dilutions and plating on chocolate agar was evaluated. Pipetting and sonicating as well as vortexing with beads consistently released the highest number of viable CFUs.
These methods were then utilized on biofilms of each organism grown for 16 h at 37 °C under 5% CO2 in 48-well plates. These 16 h biofilms were then gently washed two times with PBS (except for S. pneumoniae which was washed only once due to its more delicate biofilm structure), then either pipetted up and down for 2 min followed by sonication for 2 min in a Fisher Scientific (Pittsburgh, PA) waterbath sonicator, Model FS20, or scraped from the wells, transferred to Eppendorf tubes that contained siliconized glass beads and vortexed at the highest setting for 2 min (except for P. aeruginosa, which was vortexed for 5 min due to its more robust biofilm structure). For planktonic cultures, 6 mL of sBHI was seeded with approximately six individual colonies of freshly plated NTHI to achieve an OD490nm of 0.1, and allowed to grow at 37 °C, 5% CO2 until mid-log phase (2–3 h), before being aliquoted and subjected to the same disruption methods as listed above for biofilm cells.
For mechanically disrupted biofilm biomass reduction experiments, biofilms were first grown in an eight well chamber slide for 16 h. Biofilms were scraped from the chamber slides and pipetted as a suspension before mechanical NRel treatments. The residual biofilm was washed, stained with LIVE/DEAD® stain and visualized using CLSM. COMSTAT software was used for biomass quantification () and then the average biomass against control were plotted using GraphPad Prism (version 10.3.1)
2.4 P11 phosphocellulose activation and biofilm assays
A total of 200 mg P11 phosphocellulose resin (Whatman-Cytiva, Marlborough, MA) was washed first in 10 mL Milli-Q water, which was then removed by centrifugation at 500 rpm for 5 min, and the resin was then incubated with 10 mL 0.5 N NaOH (10 min). This treated resin was then washed with Milli-Q water once and then incubated with 10 mL 0.5 N HCl (10 min). Resin was then washed with Milli-Q water and equilibrated in 10 mL of 20 mM sodium phosphate buffer. Before use, the buffer was replaced with media to achieve a final 1.5% w/v P11 resin.
NTHI biofilms were initiated in the basolateral chamber of the transwell system (Corning Costar, Part no. 3470), for 24 h, and then P11 or sBHI (300 μL) was added to the apical chamber (1.5% w/v) for 2 h. This treatment disrupts pre-formed biofilms and releases NRel into the media within the basolateral chamber. The media from the basal chamber were then collected carefully without disrupting any remaining biofilms and centrifuged at 10,000 g for 10 min to collect NRel. NRel were then washed once with 1 mL PBS then used to assess the antibiotic sensitivity, time course experiments, and RNA isolation as mentioned below. Post-treatment, biofilms in the basolateral chamber were stained with LIVE/DEAD® stain, fixed, and visualized using CLSM. COMSTAT software was used for biomass and thickness quantification () and then the average thickness and biomass against control were plotted using GraphPad Prism (version 10.3.1).
2.5 Antibiotic sensitivity assay
After determining the appropriate antibiotic concentration to achieve ∼15%–25% planktonic killing for each organism and disrupting the biofilms or planktonic cells, as described above, the resulting cell suspensions were then diluted 100-fold into the appropriate media with or without antibiotics and allowed to incubate at 37 °C with 5% CO2 for 2 h. This was followed by serial dilutions in PBS and plating for CFUs to determine the relative killing by antibiotics compared to the no antibiotic sample for both planktonic cells and cells released from disrupted biofilms (see schematic Figure 1A).
FIGURE 1
2.6 Time course experiment
To determine the kinetic profile of antibiotic sensitivity (i.e., when sensitivity develops and how long this phenotype endures), we narrowed our focus to NTHI using the vortexing with glass beads disruption method. This generally followed the procedure outlined above for the antibiotic sensitivity assay, except that planktonic cells and cells released from disrupted biofilms were incubated with or without amoxicillin plus clavulanate (A/C) or Trimethoprim plus sulfamethoxazole (T/S) for 5, 15 min, 1, 2, 4, and 6 h. At each time point, the cells were diluted and plated as described above to determine comparative plate counts and relative antibiotic sensitivity over time.
2.7 RNA isolation and qRT-PCR
For NRel RNA isolation, 6 ml of sBHI was seeded with NTHI to achieve 2 × 105 CFU/ml into a 25 cm2 cell culture flask (Corning, Corning, NY). The flasks were incubated at 37 °C, 5% CO2 for 16 h, then gently inverted, and the medium decanted. The biofilms were washed by carefully adding 2 mL PBS and gently inverting the flask, then inverted again to remove the PBS followed by repeating for a second wash. One mL PBS was added to the flask and the biofilms were gently scraped and pipetted to remove the bacterial cells. The bacterial cell suspension was added to a 1.5 mL Eppendorf tube and centrifuged for 5 min at 4,000 × g to pellet the cells. The supernatant was removed, and the pellets were resuspended in 500 μL of PBS and transferred to new tubes that contained siliconized glass beads and vortexed for 2 min. The resulting NRel were removed to a new tube, 500 μL of pre-warmed sBHI added and incubated at 37 °C, 5% CO2 for 15 min. The cells were then centrifuged for 1 min at 15,000 × g, the supernatant aspirated, and 1 ml TRIzol™ Reagent (ThermoFisher, Waltham, MA) was immediately added to the bacterial pellet. Samples were stored at −80 °C.
For planktonic RNA isolation, 6 mL of sBHI was seeded with NTHI to achieve an OD490 nm of 0.1, and allowed to grow at 37 °C, 5% CO2 until mid-log phase (2–3 h), then centrifuged for 1 min at 15,000 × g and the supernatant aspirated. The resulting cell pellets were washed with 1 mL PBS and recentrifuged for 1 min at 15,000 × g, the supernatant aspirated, and 1 ml TRIzol™ Reagent was immediately added to the bacterial pellet. Samples were stored at −80 °C.
RNA was purified with a Qiagen RNeasy kit (Qiagen, Germantown, MD) using the optional DNase treatment to remove residual DNA, per manufacturer’s instructions. Anti-DNABII RNA was obtained, as described and used previously in and . RNA integrity was confirmed through the Qubit RNA IQ assay (Qubit 4 Fluorometer, Invitrogen). RNA was only used downstream if it had a score of 9.0 or higher (out of 10.0). Quantitative reverse transcription-PCR (qRT-PCR) was used to measure relative gene expression via the Superscript III Platinum SYBR Green One-Step qRT-PCR kit (ThermoFisher, Waltham, MA r) per manufacturer’s instructions. Gene expression was normalized to 16S, and relative expression was calculated by the comparative (ΔΔCT) method, with fold change in gene expression expressed as 2–ΔΔCT. Results represent the mean of three independent biofilm preparations on separate days, each assayed in duplicate. The primers used (see Supplementary Table 1) were previously utilized in publications from our group (; ) and were confirmed in this study by melt curve analysis, indicating specific amplification (e.g., single peaks) for each primer across each RNA tested.
3 Results
3.1 Determination of mechanical disruption methods
To test our hypothesis that rapid biofilm disruption can produce the NRel phenotype, we first needed to identify the mechanical methods that could best disrupt biofilms while producing the greatest amount of viable, released cells. As a proof of concept, we wanted to evaluate disruption methods that were very rapid in nature and could be executed in the span of minutes, to emulate other rapid, reagent-based methods. As such, NTHI was grown for 16 h at 37 °C, 5% CO2 and the resulting 16 h biofilms were washed and subjected to combinations of water bath sonication for up to 5 min, vortexing with and without glass beads for up to 5 min, or multiple triturating with a pipet for variable durations to evaluate the viability of the resulting, released cells. Triturating and sonicating for 2 or 5 min each, as well as vortexing with beads for 0.5–5 min consistently released the greatest number of CFUs (Supplementary Figure 1A). To maintain consistency and keep the disruption time short, we opted to utilize the following methods of mechanical disruption in downstream experiments: triturating vigorously for 2 min followed by sonication for 2 min or scraping up the biofilm and vortexing with glass beads for 2 min. To determine the effectiveness of disruption (i.e., were individual cells or cell aggregates being released), we stained the cells released from disrupted biofilms with crystal violet and compared them to planktonic NTHI viewed under light microscopy. Both the pipetting and sonication as well as the vortexing with glass beads methodologies were able to yield mostly small cell aggregates, with few individual cells, visually different from unaggregated planktonically grown NTHI (Supplementary Figure 1B). The cell aggregation observed here in disrupted preparations is similar to those seen with anti-DNABII exposure and is another phenotype of NRel, as previously reported (). In addition to the visual inspection of NRel via crystal violet staining (Supplementary Figure 1B), the effectiveness of physical biofilm removal from the chamber slide was also determined and shown in Supplementary Figure 2; the scraping process removed >99% of the original biofilm as judged by the reduction in biomass. Finally, we wanted to ensure that the mechanical disruption itself did not affect cell viability. To that end, we tested subsets of planktonic NTHI cells with and without beads and vortexing for 2 min at low and high settings (settings 3 and 10 using the Fisher analog vortex mentioned above) to determine relative number of viable bacteria (Supplementary Figure 3). Neither the presence of beads nor the relative forces applied by vortexing demonstrated a significant difference in viability as measured by plate counts for CFUs of the planktonic suspensions, indicating that this disruption method did not result in cell death in and of itself.
3.2 Increased antibiotic sensitivity of cells released from mechanically disrupted biofilms
First, and perhaps most important, among the hallmarks of the NRel phenotype is the increased antibiotic sensitivity compared to planktonically grown cells. Here, we sought to determine if our mechanically disrupted biofilm cells displayed increased antibiotic sensitivity. Using the antibiotics outlined in Table 1 and the disruption methods described above, we tested both planktonically grown cells and disrupted biofilm cells of each organism in the presence or absence of antibiotic which were then serially diluted and plated for CFUs (Figure 1A). The percentage of cells killed was determined by comparative plate counts of each cell type with and without antibiotics. Increased % killing of the cells released from disrupted biofilms compared to planktonically grown cells would likely indicate the production of the NRel phenotype. Remarkably, both pipetting/sonication and vortexing with beads yielded bacterial populations that were significantly more sensitive to antibiotic killing compared to their planktonic counterparts for all four tested pathogens (Figures 1B–E). This demonstrates that the increased antibiotic sensitivity characteristic of the NRel phenotype was produced using both methods, albeit to a somewhat greater extent when vortexing with glass beads.
3.3 Phosphocellulose (P11)-mediated sequestration of positively charged biomolecules promotes disruption of established biofilms with generation of NRels
As a second approach, we wanted to evaluate a non-mechanical but still rapid form of physical disruption of an NTHI biofilm. Electrostatic interactions between negatively charged DNA and positively charged DNABII proteins (e.g., HU and IHF) help stabilize DNA structures within the biofilm matrix (; ). Previous studies have shown that depletion of positively charged molecules such as Mg++ from biofilms increases the susceptibility of NTHI to antibiotic treatment (), while targeted removal of DNABII proteins from the biofilm matrix due to the action of specific antibodies results in rapid, significant biofilm collapse with concomitant release of NRels (; ; ; ; ). Ergo, we hypothesized that removal of positively charged molecules may rapidly destabilize the biofilms, to release NRels. To test that hypothesis, we employed phosphocellulose (P11), a well-established cation exchanger and DNA mimetic historically used to purify DNABII proteins (; ).
In this approach, we utilized a transwell system in which NTHI biofilms were allowed to establish in the basolateral chamber, whereas P11 was added to the apical chamber with the two chambers separated by a 0.4 μm pore membrane (Figure 2A). This setup would theoretically create an equilibrium shift through diffusion and accumulation of small molecules, such as DNABII proteins and other small positively charged species into the apical chamber, while preventing the similar passage of bacterial cells. The apical chamber was supplemented with 0% (w/v) P11 (media control) or 1.5% (w/v) P11, all in sBHI, then incubated for 2 h and analyzed for biomass and average thickness. As shown in Figure 2B, P11 significantly reduced biofilm thickness and biomass, which confirmed biofilm disruption capability. In parallel assays, we collected NRel cells from the basolateral chamber, and comparative plate counts were evaluated in the presence or absence of antibiotics as described above. For consistency, the same antibiotics and antibiotic concentrations that yielded 15%–25% killing of planktonic NTHI were used, as listed in Table 1. We observed a significant increase in killing of the cells released from P11 disrupted biofilms compared to planktonic (Figure 2C). Remarkably, P11 disruption resulted in even greater released bacterial killing percentages than mechanical disruption in NTHI (Figure 1B). Altogether, three different methods of rapid physical disruption, albeit to different extents, were able to induce the increased antibiotic sensitivity phenotype seen in NRel.
FIGURE 2
3.4 Kinetic profile of antibiotic sensitivity of NTHI NRel generated by rapid disruption
We next wanted to determine both when enhanced antibiotic sensitivity was first detectable and for how long it persisted, as a measure of the duration of the NRel state post disruption. We narrowed our focus to NTHI with either mechanical disruption (e.g., vortexing with glass beads) or via co-incubation with P11, as shown previously, with the exception that planktonic cells and cells released from disrupted biofilms were incubated with or without the antibiotics A/C or T/S for 5, 15 min, 1, 2, 4, and 6 h. At each time point, the cells were diluted and plated to determine comparative plate counts. For our mechanical method, the increased susceptibility to A/C of the cells released from disrupted biofilms started to differentiate from planktonic at 15 min, reached significance that was maintained from 1 to 4 h, then started to return to near planktonic levels by 6 h. Interestingly, mechanically disrupted NTHI had a much more muted response to T/S, wherein relative killing was only significantly greater than that observed for planktonically grown NTHI at the 2-h time point before falling back to near planktonic levels at 4 and 6 h (Figure 3A). Upon disrupting the biofilms with the P11 resin, the increased susceptibility to A/C of the cells released from disrupted biofilms significantly differentiated from planktonic sensitivity between 15 min and 4 h, peaking at 2 h and falling back to near planktonic levels by 4 and 6 h. When NRel resulting from co-incubation with P11 were treated with T/S, increased sensitivity to killing reached significance between 1 and 4 h, before trending back to planktonic levels at 6 h (Figure 3B).
FIGURE 3
3.5 Relative gene expression in NTHI NRel
Finally, we wanted to determine if NTHI NRel as generated by either mechanical disruption or co-incubation with P11 exhibited similar gene expression profiles to those generated via the action of the anti-DNABII monoclonal antibody (). We have previously shown a strong similarity between genetic markers of NRel cells and lag phase bacteria. To test this in our cells released from mechanical and P11 disrupted biofilms, we used qRT-PCR to examine the relative expression of fis, a signature and predominant gene canonically associated with lag phase of bacterial growth (). Expression was significantly greater in the three populations of NRel tested compared to planktonic NTHI (Figure 4A). Interestingly, the different methods of generating the NRel cells demonstrated significant differences from each other, with the mechanical disruption resulting in significantly greater fis expression (∼400-fold) than the anti-DNABII treated cells (over 200-fold), which themselves were significantly greater than the cells released from P11 disrupted biofilms (almost 100-fold). Despite these metabolic differences however, collectively these results suggest that all three methods release NRel from biofilm residence into a phenotypic state that appears to mimic lag phase.
FIGURE 4
Changes to multiple processes, including drug uptake, efflux, and the direct mechanism of an antibiotic, can result in sensitivity to antibiotic killing in bacteria (). To compare our disruption methods against our previous results and verify the possible mechanisms for the enhanced antibiotic sensitivities, we also examined the relative gene expression of folP and acrR via qRT-PCR, two additional targeted genes that are canonically associated with lag phase and that we have shown are upregulated in NRel induced by the action of anti-DNABII (). folP, which encodes the protein target for sulfamethoxazole (), was significantly increased in each NRel population compared to planktonic NTHI (Figure 4B). Whereas both the mechanical and anti-DNABII disrupted NRel showed significantly greater folP expression than that of the P11 NRel, they were not significantly different from each other.
β-lactam antibiotics can be transported via the ArcAB efflux pump, which is controlled by the transcriptional repressor ArcR (). Enhanced expression of which, we argue, would result in the increased sensitivity of NTHI to A/C (). Relative expression of acrR was significantly elevated in all three populations of NRel (Figure 4C). While their acrR expression profiles were not significantly different from each other, they did trend toward the pattern seen in the other tested lag phase genes. Collectively, these patterns of relative gene expression support the observed enhanced sensitivities to antibiotic mediated killing, which is consistent with the NRel phenotype.
4 Discussion
The global rise of antimicrobial resistance (AMR), along with the recalcitrant and recurrent nature of biofilm-related diseases, warrant the need for new technologies to combat them. While many such strategies are currently in different stages of development and testing, the predominant option of treatment remains with antibiotics that are growing increasingly ineffective. Thus, inhibiting biofilm formation and/or disrupting biofilm-resident organisms to extract them from the protective shells of their EPS matrices is of paramount importance to clearing these infections or ideally, preventing them altogether.
In previous studies, we have shown that a monoclonal antibody that targets the DNABII family of bacterial DNA-binding proteins is highly effective at driving the collapse of biofilms consisting of single or multiple species of pathogenic bacteria, and releasing them into a transient, yet highly vulnerable state. Indeed, regardless of the specific mode of release, multiple laboratories have shown increased sensitivity to antibiotics once the resident bacteria are free of the biofilm (; , ; ; ; ; ; ; ; ; ; ; ). triggered S. pneumoniae biofilm dispersion by interkingdom signaling induced by virus infection, with significant dispersal seen within 10–30 min, and a resulting antibiotic susceptibility lasting for at least 2 h. showed that P. aeruginosa biofilms could be dispersed within minutes by reduction in cyclic-di-GMP levels with increased antibiotic susceptibility also lasting 2 h. In , P. aeruginosa biofilms were triggered to disperse by cues such as nitric oxide and glutamate. Dispersion was detected within 15 min after induction with varying durations of increased antibiotic susceptibility based on the trigger and antibiotics used (). , were able to disrupt biofilms of staphylococci and P. aeruginosa, respectively, in as little as 2 min of treatment with DNase I, although they did not specifically look at the duration of increased antibiotic susceptibility. Other methods that induce this newly released phenotype of enhanced susceptibility include depletion of pyruvate availability (), inability to aerobically respire (), and the use of disruptive nanoparticles (), among others. While the methods differ and offer varying windows of increased antibiotic susceptibility, fast bacterial biofilm disruption methods share the ability to confer the increased antibiotic sensitivity phenotype.
In this NRel state, bacteria are highly susceptible to MIC and even sub-MIC antibiotic concentrations previously measured for the planktonic state (, ), as well as host immune clearance (). NRel also exhibit a unique gene expression profile, such as upregulation of genes canonically associated with lag phase, outer membrane porins and multi-drug efflux pump repressors, as well as down-regulation in genes involved in protective functions e.g., mitigation of oxidative stress ().
Herein, we have shown that bacterial cells that resulted from our rapid biofilm disruption methodologies displayed the same three hallmarks of the NRel phenotype, particularly as demonstrated by NTHI. The mechanical disruption methods used were able to induce 1.5- to 2-fold increased antibiotic sensitivity in NTHI, MRSA, P. aeruginosa, and S. pneumoniae, similar to the 1.5- to 2.5-fold increase to antibiotic sensitivity seen in our previous anti-DNABII method of biofilm disruption (, ), while the P11 method of NTHI biofilm disruption was able to induce a 3- to 4-fold increase in antibiotic sensitivity. Although the possibility remains that this increase in antibiotic sensitivity could also reflect sublethal injuries to the cells, such as membrane damage, altered membrane permeability, or oxidative stress effects, the uniform disruption methods across both planktonic and NRel cells control for potential sublethal damage, likely reflecting an inherent biological difference rather than a procedural artifact. Furthermore, this increased antibiotic susceptibility occurred in a time-dependent manner in NTHI, consistent with the NRel phenotype as seen in our anti-DNABII rapid release approach (). While time to reach a significant increase in relative antibiotic killing of NRel compared to planktonic NTHI differed between each method, significant differences were observed in NRel populations induced by each method between 1 and 4 h, with peak differences generally at 2 h post-disruption, before trending back to near-planktonic levels within 6 h. Earlier work has also shown that anti-DNABII induced NTHI NRel displayed preferential killing by a β-lactam antibiotic than by a sulfonamide (), consistent with our current results, albeit to different extents. Whereas the cells released from anti-DNABII disrupted biofilms did not reach a significant increase in antibiotic sensitivity to T/S, the cells released from mechanically disrupted biofilms reached significance at 2 h and the cells released from P11 disrupted biofilms reached significance from 1 to 4 h. Still, it is remarkable that these different experimental designs show such similar kinetic profiles.
Rapidly disrupted NTHI also exhibited similar significant gene expression profiles in the specific genes tested compared to planktonic cells. While the upregulation of fis, folP, and acrR is consistent with prior observations of a lag-phase-like signature, future work will include a thorough analysis of this broader physiological state. Although the methods used displayed significant or trending differences from each other, the duration of treatment prior to the collection of NRel for RNA isolation could help to explain the differences seen in relative gene expression. We acknowledge that the 15-min incubation required for the preparation of RNA (the shortest period wherein multiple samples could be prepared in parallel with the lowest precision error) could affect the desired instantaneous transcriptional state of the bacteria. It may be that the isolated RNA captured in part an early adaptive state rather than the instantaneous NRel transcription, an unavoidable conceit in our experimental results. That said, our data in Figure 3 shows that antibiotic sensitivities increase with time for the first few hours after bacteria are released from the biofilm regardless of the NRel technique. Thus, although it is possible we have failed to identify a new window of antibiotic sensitivities prior to 15 min, we think this unlikely. While different disruption rates or the extent of biofilm disruption, i. e., producing single cells as opposed to different magnitudes of aggregates, could explain the differences seen between the methods examined here and previously, the fact that there are differences means that while all these quickly released formerly biofilm-resident bacteria have similar NRel phenotypes, they are not likely identical. While the NRel are clearly bigger than planktonic cells but much smaller than the original biofilm, it also remains unclear to what degree the EPS was affected. Future work will include assessing any changes to the quantity and composition of the EPS in each NRel state as well as directly testing the hypothesis that the properties of NRel bacteria are in part dependent on the method from which they are derived.
Many aspects of this vulnerable NRel state of NTHI have been elucidated in our previous studies (, ; , ; ). The bacteria newly released from biofilms appear to resemble bacteria in lag phase, as observed by others (), and similarly display significant up- or downregulation of specifically profiled genes. In P. aeruginosa freshly dispersed via active programmed release, genes associated with type IV pili, pyoverdine, type III and IV secretion systems and antibiotic resistance are down-regulated, while genes involved in swimming motility, Hxc type II secretion systems, various virulence factors and metabolic and energy-generating systems are up-regulated (). Whereas there is often increased virulence reported in freshly dispersed cells (; ), this is not a phenomenon observed with rapidly-disrupted NRel (). In contrast, when rapidly released from biofilm residence by physical disruption, as opposed to programmed dispersal, we believe that bacteria are in a state where they are initially poorly equipped to handle the deleterious effects of antibiotics or innate immune effectors. This may be explained by the fact that bacteria resident within a biofilm are often metabolically less active (). Though these defensive abilities are eventually regained through adequate gene expression, the NRel phenotype nonetheless provides an opportunity for more effective eradication of the formerly biofilm-resident bacteria.
The biofilm matrix is maintained by the interaction of various macromolecules. Chief among these is eDNA. Due to the polyanionic nature of eDNA, positively charged molecules are critical in the maintenance of its structure and structural integrity. Indeed, we have discovered that the DNABII family of basic DNA binding proteins fulfills the aforementioned role (; ). Targeted removal of DNABII proteins collapses the preformed biofilms (; ; ; ) with concomitant susceptibility of released bacteria to both antibiotics and innate immune effectors. Moreover, other methods of positively charged molecule depletion e.g., depletion of divalent cations from biofilms using EDTA also creates a sensitizing effect on NTHI biofilm (). Our new data reported here are consistent with the notion that depletion of positively charged molecules via the P11 cation exchanger resin was sufficient to rapidly undermine biofilms to generate released cell populations that are in the NRel state. While it is tempting to assume that the DNABII proteins are likely the primary species sequestered by the P11 resin, this idea is largely inferential as it remains to be seen if they are the only positively charged molecules that upon depletion elicit disruption of biofilms. Although it is beyond the scope of this manuscript, future work will include the characterization of the specific mechanisms of P11 biofilm disruption. While the physiochemical properties of P11 may limit direct clinical suitability, it clearly demonstrates proof-of-principle efficacy.
The noted similarities between rapid, physical means of disruption and reagent-based methods indicate that the production of the NRel state is consistent with a rate-dependent model, and we can likely induce the NRel phenotype via a rapid, physical approach independent of the means to accomplish disruption. As such, we posit that the relative speed of the disruption method matters, in that quickly releasing bacteria promotes the greatest shock to the cells, leaving them the most vulnerable and ill-equipped to deal with standard treatment options and effectors of the innate immune system. Per our hypothesis, slower methods of bacterial release would likely allow the bacteria time to adapt and equip themselves with the necessary means to survive outside of the protection of a biofilm. As demonstrated by the NRel phenotype’s transient nature, there is a time limit before the bacteria adapt back to their free-living, planktonic state of growth. Missing that window of opportunity to eradicate these highly vulnerable cells would make treatment that much more difficult.
One major limitation of the approaches used herein as a therapeutic method is that it is often not feasible to physically access the sites of internal infections, thereby making mechanical disruption of these biofilms extremely difficult. Although this study provides proof-of-concept to further our understanding of this unique NRel phenotype, there are opportunities for the usage of rapid, physical means of disruption in clinical practice. Mechanical disruption using jets of water have been developed and used for the removal of pathogenic biofilms, such as irrigation and debridement of surgical site infections and indwelling devices (). Although these jets can remove a significant amount of biofilm from the area, there is the possibility of the released bacteria re-seeding and spreading across the site surface within the water itself to re-establish infection at the same or different location. Indeed, it is also unlikely that biofilm disruption by water jets would break up the bacteria into small enough aggregates or even single cells, necessitating further fine tuning to these procedures to achieve an NRel state. This obstacle likely contributes to the low success rate of irrigation and debridement alone in treating periprosthetic infections (). Most approaches to biofilm-specific therapies in these situations still consist of conventional antibiotics or topical antimicrobials (). However, one could envision the addition of antimicrobial agents to more advanced water-based jets so that as they create the necessary mechanical forces to disrupt the biofilm, the fluid simultaneously acts as a delivery device for an appropriate antimicrobial.
Nonetheless, we continue to investigate and support our approach to treating bacterial biofilm diseases, wherein our novel anti-DNABII antibody is administered in a therapeutic regimen, with or without the simultaneous co-administration of an effective antibiotic. Taken together, beyond our further understanding of the NRel phenotype, our results are significant in that they shift the conversation from molecule-specific effects toward physiological state transitions and suggest that fast acting treatments that disrupt biofilms, rather than trigger programmed dispersal, whether reagent-based or otherwise, are likely to induce a similar NRel state.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
Ethical approval was not required for the studies involving humans because NTHI strain 86-028NP was originally obtained from a deidentified clinical isolate from the nasopharynx of a child at what was then Columbus Children’s Hospital undergoing tympanostomy tube insertion for chronic otitis media. The studies were conducted in accordance with the local legislation and institutional requirements. The human samples used in this study were acquired from a by-product of routine care or industry. Written informed consent to participate in this study was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and the institutional requirements.
Author contributions
JW: Investigation, Writing – original draft, Formal analysis, Visualization, Software, Data curation, Validation, Methodology, Writing – review & editing. KM: Writing – review & editing, Formal analysis, Writing – original draft, Methodology, Investigation, Data curation. AH: Data curation, Writing – review & editing, Investigation, Methodology. LB: Conceptualization, Writing – review & editing, Supervision, Funding acquisition, Resources. SG: Resources, Project administration, Writing – review & editing, Supervision, Conceptualization.
Funding
The author(s) declared that financial support was received for this work and/or its publication. This work was funded by the NIH (R01DC003915 to LB).
Acknowledgments
We thank John Buzzo for his preliminary work in the development of the P11 biofilm disruption technique and Katie Wilbanks for the gift of α-DNABII RNA previously generated and described in and , as well as for her thoughtful discussion and technical assistance with kinetics and qRT-PCR methodologies. We also thank Kelly Moore and Frankie Biffath for their assistance with preliminary experimental design and data collection. We are grateful to Nikola Kurbatfinski and Audrey Duff for thoughtful discussions and technical assistance with assay methodology (antibiotic sensitivity and qRT-PCR, respectively).
Conflict of interest
SG and LB are inventors of technology and hold patents related to the DNABII-directed approach, rights to which have been licensed to Clarametyx Biosciences, Inc. SG and LB are Scientific Founders and Scientific Advisory Board Co-Chairs of Clarametyx Biosciences, Inc.
The remaining author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2026.1734540/full#supplementary-material
References
1
AnesJ.MccuskerM. P.FanningS.MartinsM. (2015). The ins and outs of RND efflux pumps in Escherichia coli.Front. Microbiol.6:587. 10.3389/fmicb.2015.00587
2
BuzzoJ. R.DevarajA.GloagE. S.JurcisekJ. A.Robledo-AvilaF.KeslerT.et al. (2021). Z-form extracellular DNA is a structural component of the bacterial biofilm matrix.Cell1845740–5758.e17. 10.1016/j.cell.2021.10.010
3
CámaraM.GreenW.MacpheeC. E.RakowskaP. D.RavalR.RichardsonM. C.et al. (2022). Economic significance of biofilms: A multidisciplinary and cross-sectoral challenge.NPJ Biofilms Microbiomes8:42. 10.1038/s41522-022-00306-y
4
CavaliereR.BallJ. L.TurnbullL.WhitchurchC. B. (2014). The biofilm matrix destabilizers, EDTA and DNaseI, enhance the susceptibility of nontypeable Hemophilus influenzae biofilms to treatment with ampicillin and ciprofloxacin.Microbiologyopen3557–567. 10.1002/mbo3.187
5
ChambersJ. R.ChernyK. E.SauerK. (2017). Susceptibility of Pseudomonas aeruginosa dispersed cells to antimicrobial agents is dependent on the dispersion cue and class of the antimicrobial agent used.Antimicrob. Agents Chemother.61:e00846-17. 10.1128/AAC.00846-17
6
ChaoY.MarksL. R.PettigrewM. M.HakanssonA. P. (2015). Streptococcus pneumoniae biofilm formation and dispersion during colonization and disease.Front. Cell. Infect. Microbiol.4:194. 10.3389/fcimb.2014.00194
7
ChuaS. L.LiuY.YamJ. K. H.ChenY.VejborgR. M.TanB. G. C.et al. (2014). Dispersed cells represent a distinct stage in the transition from bacterial biofilm to planktonic lifestyles.Nat. Commun.5:4462. 10.1038/ncomms5462
8
CostertonJ. W.StewartP. S.GreenbergE. P. (1999). Bacterial biofilms: A common cause of persistent infections.Science2841318–1322. 10.1126/science.284.5418.1318
9
DevarajA.BuzzoJ.RoccoC. J.BakaletzL. O.GoodmanS. D. (2018). The DNABII family of proteins is comprised of the only nucleoid associated proteins required for nontypeable Haemophilus influenzae biofilm structure.Microbiologyopen7:e00563. 10.1002/mbo3.563
10
DevarajA.JusticeS. S.BakaletzL. O.GoodmanS. D. (2015). DNABII proteins play a central role in UPEC biofilm structure.Mol. Microbiol.961119–1135. 10.1111/mmi.12994
11
FabbriS.JohnstonD. A.RmaileA.GottenbosB.De JagerM.AspirasM.et al. (2016). Streptococcus mutans biofilm transient viscoelastic fluid behaviour during high-velocity microsprays.J. Mech. Behav. Biomed. Mater.59197–206. 10.1016/j.jmbbm.2015.12.012
12
FlemingD.ChahinL.RumbaughK. (2017). Glycoside hydrolases degrade polymicrobial bacterial biofilms in wounds.Antimicrob. Agents Chemother.61:e01998-16. 10.1128/AAC.01998-16
13
FlemingD.RumbaughK. (2018). The consequences of biofilm dispersal on the host.Sci. Rep.8:10738. 10.1038/s41598-018-29121-2
14
FlemingD.RumbaughK. P. (2017). Approaches to dispersing medical biofilms.Microorganisms5:15. 10.3390/microorganisms5020015
15
FlemmingH.-C.WingenderJ. (2010). The biofilm matrix.Nat. Rev. Microbiol.8623–633. 10.1038/nrmicro2415
16
GoodmanS. D.BakaletzL. O. (2022). Bacterial biofilms utilize an underlying extracellular DNA matrix structure that can be targeted for biofilm resolution. Microorganisms10:466. 10.3390/microorganisms10020466
17
GoodwineJ.GilJ.DoironA.ValdesJ.SolisM.HigaA.et al. (2019). Pyruvate-depleting conditions induce biofilm dispersion and enhance the efficacy of antibiotics in killing biofilms in vitro and in vivo.Sci. Rep.9:3763. 10.1038/s41598-019-40378-z
18
GuéroultM.BoittinO.MauffretO.EtchebestC.HartmannB. (2012). Mg2+ in the major groove modulates B-DNA structure and dynamics.PLoS One7:e41704. 10.1371/journal.pone.0041704
19
GuilhenC.ForestierC.BalestrinoD. (2017). Biofilm dispersal: Multiple elaborate strategies for dissemination of bacteria with unique properties.Mol. Microbiol.105188–210. 10.1111/mmi.13698
20
GunnJ. S.BakaletzL. O.WozniakD. J. (2016). What’s on the outside matters: The role of the extracellular polymeric substance of gram-negative biofilms in evading host immunity and as a target for therapeutic intervention.J. Biol. Chem.29112538–12546. 10.1074/jbc.R115.707547
21
GuptaD.SinghA.KhanA. U. (2017). Nanoparticles as efflux pump and biofilm inhibitor to rejuvenate bactericidal effect of conventional antibiotics.Nanoscale Res. Lett.12:454. 10.1186/s11671-017-2222-6
22
HeydornA.NielsenA. T.HentzerM.SternbergC.GivskovM.ErsbøllB. K.et al. (2000). Quantification of biofilm structures by the novel computer program COMSTAT.Microbiology1462395–2407. 10.1099/00221287-146-10-2395
23
HowlinR. P.CathieK.Hall-StoodleyL.CorneliusV.DuignanC.AllanR. N.et al. (2017). Low-dose nitric oxide as targeted anti-biofilm adjunctive therapy to treat chronic Pseudomonas aeruginosa infection in cystic fibrosis.Mol. Ther.252104–2116. 10.1016/j.ymthe.2017.06.021
24
HuovinenP. (2001). Resistance to trimethoprim-sulfamethoxazole.Clin. Infect. Dis.321608–1614. 10.1086/320532
25
JurcisekJ. A.KurbatfinskiN.WilbanksK. Q.RhodesJ. D.GoodmanS. D.BakaletzL. O. (2025). Mycobacterium abscessus biofilm cleared from murine lung by monoclonal antibody against bacterial DNABII proteins.J. Cyst. Fibros.24374–381. 10.1016/j.jcf.2025.01.013
26
KaliaM.SauerK. (2024). Distinct transcriptome and traits of freshly dispersed Pseudomonas aeruginosa cells.mSphere9:e0088424. 10.1128/msphere.00884-24
27
KaplanJ. B. (2010). Biofilm dispersal: Mechanisms, clinical implications, and potential therapeutic uses.J. Dent. Res.89205–218. 10.1177/0022034509359403
28
KaplanJ. B.LovetriK.CardonaS. T.MadhyasthaS.SadovskayaI.JabbouriS.et al. (2012). Recombinant human DNase I decreases biofilm and increases antimicrobial susceptibility in staphylococci.J. Antibiot.6573–77. 10.1038/ja.2011.113
29
KapoorG.SaigalS.ElongavanA. (2017). Action and resistance mechanisms of antibiotics: A guide for clinicians.J. Anaesthesiol. Clin. Pharmacol.33300–305. 10.4103/joacp.JOACP_349_15
30
KolpenM.KraghK. N.EncisoJ. B.Faurholt-JepsenD.LindegaardB.EgelundG. B.et al. (2022). Bacterial biofilms predominate in both acute and chronic human lung infections.Thorax771015–1022. 10.1136/thoraxjnl-2021-217576
31
KooH.AllanR. N.HowlinR. P.StoodleyP.Hall-StoodleyL. (2017). Targeting microbial biofilms: Current and prospective therapeutic strategies.Nat. Rev. Microbiol.15740–755. 10.1038/nrmicro.2017.99
32
KurbatfinskiN.GoodmanS. D.BakaletzL. O. (2022). A humanized monoclonal antibody potentiates killing of diverse biofilm-forming respiratory tract pathogens by antibiotics.Antimicrob. Agents Chemother.66:e0187721. 10.1128/AAC.01877-21
33
KurbatfinskiN.KramerC. N.GoodmanS. D.BakaletzL. O. (2023). ESKAPEE pathogens newly released from biofilm residence by a targeted monoclonal are sensitized to killing by traditional antibiotics.Front. Microbiol.14:1202215. 10.3389/fmicb.2023.1202215
34
LebeauxD.GhigoJ. M.BeloinC. (2014). Biofilm-related infections: Bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.Microbiol. Mol. Biol. Rev.78510–543. 10.1128/MMBR.00013-14
35
LiY.PetrovaO. E.SuS.LauG. W.PanmaneeW.NaR.et al. (2014). BdlA, DipA and induced dispersion contribute to acute virulence and chronic persistence of Pseudomonas aeruginosa.PLoS Pathog.10:e1004168. 10.1371/journal.ppat.1004168
36
MahT. F. (2012). Biofilm-specific antibiotic resistance.Future Microbiol.71061–1072. 10.2217/fmb.12.76
37
MarksL. R.DavidsonB. A.KnightP. R.HakanssonA. P. (2013). Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease.mBio4:e00438-13. 10.1128/mbio.00438-13
38
MirzaeiR.MohammadzadehR.AlikhaniM. Y.Shokri MoghadamM.KarampoorS.KazemiS.et al. (2020). The biofilm-associated bacterial infections unrelated to indwelling devices.IUBMB Life721271–1285. 10.1002/iub.2266
39
MokrzanE. M.AhearnC. P.BuzzoJ. R.NovotnyL. A.ZhangY.GoodmanS. D.et al. (2020). Nontypeable Haemophilus influenzae newly released (NRel) from biofilms by antibody-mediated dispersal versus antibody-mediated disruption are phenotypically distinct.Biofilm2:100039. 10.1016/j.bioflm.2020.100039
40
MokrzanE. M.NovotnyL. A.BrockmanK. L.BakaletzL. O. (2018). Antibodies against the majority subunit (PilA) of the type IV pilus of nontypeable Haemophilus influenzae disperse Moraxella catarrhalis from a dual-species biofilm.mBio9:e02423-18. 10.1128/mBio.02423-18
41
NashH. A.RobertsonC. A. (1981). Purification and properties of the Escherichia coli protein factor required for lambda integrative recombination.J. Biol. Chem.2569246–9253. 10.1016/s0021-9258(19)52537-6
42
NovotnyL. A.AmerA. O.BrocksonM. E.GoodmanS. D.BakaletzL. O. (2013). Structural stability of Burkholderia cenocepacia biofilms is reliant on eDNA structure and presence of a bacterial nucleic acid binding protein.PLoS One8:e67629. 10.1371/journal.pone.0067629
43
NovotnyL. A.JurcisekJ. A.GoodmanS. D.BakaletzL. O. (2016). Monoclonal antibodies against DNA-binding tips of DNABII proteins disrupt biofilms in vitro and induce bacterial clearance in vivo.EBioMedicine10, 33–44. 10.1016/j.ebiom.2016.06.022
44
PetrovaO. E.SauerK. (2016). Escaping the biofilm in more than one way: Desorption, detachment or dispersion.Curr. Opin. Microbiol.3067–78. 10.1016/j.mib.2016.01.004
45
RedmanW. K.WelchG. S.WilliamsA. C.DamronA. J.NorthcutW. O.RumbaughK. P. (2021). Efficacy and safety of biofilm dispersal by glycoside hydrolases in wounds.Biofilm3:100061. 10.1016/j.bioflm.2021.100061
46
RoccoC. J.BakaletzL. O.GoodmanS. D. (2018). Targeting the HUβ protein prevents Porphyromonas gingivalis from entering into preexisting biofilms.J. Bacteriol.200:e00790-17. 10.1128/JB.00790-17
47
RolfeM. D.RiceC. J.LucchiniS.PinC.ThompsonA.CameronA. D.et al. (2012). Lag phase is a distinct growth phase that prepares bacteria for exponential growth and involves transient metal accumulation.J. Bacteriol.194686–701. 10.1128/JB.06112-11
48
RumbaughK. P.SauerK. (2020). Biofilm dispersion.Nat. Rev. Microbiol.18571–586. 10.1038/s41579-020-0385-0
49
SauerK.CullenM. C.RickardA. H.ZeefL. A.DaviesD. G.GilbertP. (2004). Characterization of nutrient-induced dispersion in Pseudomonas aeruginosa PAO1 biofilm.J. Bacteriol.1867312–7326. 10.1128/JB.186.21.7312-7326.2004
50
SharmaD.MisbaL.KhanA. U. (2019). Antibiotics versus biofilm: An emerging battleground in microbial communities.Antimicrob. Resist. Infect. Control8:76. 10.1186/s13756-019-0533-3
51
SirakovaT.KolattukudyP. E.MurwinD.BillyJ.LeakeE.LimD.et al. (1994). Role of fimbriae expressed by nontypeable Haemophilus influenzae in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A.Infect. Immun.622002–2020. 10.1128/iai.62.5.2002-2020.1994
52
UruénC.Chopo-EscuinG.TommassenJ.Mainar-JaimeR. C.ArenasJ. (2020). Biofilms as promoters of bacterial antibiotic resistance and tolerance.Antibiotics10:3. 10.3390/antibiotics10010003
53
Van AckerH.Van DijckP.CoenyeT. (2014). Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms.Trends Microbiol.22326–333. 10.1016/j.tim.2014.02.001
54
VestbyL. K.GronsethT.SimmR.NesseL. L. (2020). Bacterial biofilm and its role in the pathogenesis of disease.Antibiotics9:59. 10.3390/antibiotics9020059
55
VorgiasC. E.WilsonK. S. (1991). A rapid purification procedure of recombinant integration host factor from Escherichia coli.Protein Expr. Purif.2317–320. 10.1016/1046-5928(91)90089-2
56
WhitchurchC. B.Tolker-NielsenT.RagasP. C.MattickJ. S. (2002). Extracellular DNA required for bacterial biofilm formation.Science295:1487. 10.1126/science.295.5559.1487
57
WilbanksK. Q.MokrzanE. M.KeslerT. M.KurbatfinskiN.GoodmanS. D.BakaletzL. O. (2023). Nontypeable Haemophilus influenzae released from biofilm residence by monoclonal antibody directed against a biofilm matrix component display a vulnerable phenotype.Sci. Rep.13:12959. 10.1038/s41598-023-40284-5
58
WilleJ.CoenyeT. (2020). Biofilm dispersion: The key to biofilm eradication or opening Pandora’s box?Biofilm2:100027. 10.1016/j.bioflm.2020.100027
59
ZemkeA. C.D’amicoE. J.SnellE. C.TorresA. M.KasturiarachiN.BombergerJ. M. (2020). Dispersal of epithelium-associated Pseudomonas aeruginosa biofilms.mSphere5:e00630-20. 10.1128/mSphere.00630-20
60
ZemkeA. C.ShivaS.BurnsJ. L.MoskowitzS. M.PilewskiJ. M.GladwinM. T.et al. (2014). Nitrite modulates bacterial antibiotic susceptibility and biofilm formation in association with airway epithelial cells.Free Radic. Biol. Med.77307–316. 10.1016/j.freeradbiomed.2014.08.011
Summary
Keywords
antibiotic sensitivity, bacterial biofilms, disruption, newly released, NTHI
Citation
Wickham J, More KR, Hendricks AL, Bakaletz LO and Goodman SD (2026) Rapid means of biofilm disruption induce the newly released (NRel) phenotype of enhanced antibiotic sensitivity. Front. Microbiol. 17:1734540. doi: 10.3389/fmicb.2026.1734540
Received
28 October 2025
Revised
03 March 2026
Accepted
11 March 2026
Published
10 April 2026
Volume
17 - 2026
Edited by
Uelinton Manoel Pinto, University of São Paulo, Brazil
Reviewed by
Stanley Brul, University of Amsterdam, Netherlands
Mohammad Abid, Jamia Millia Islamia, India
Kashish Azeem, Jamia Millia Islamia, India
Updates
Copyright
© 2026 Wickham, More, Hendricks, Bakaletz and Goodman.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Steven D. Goodman, steven.goodman@nationwidechildrens.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.